Literature DB >> 11337025

The psychobiology of anxiolytic drugs. Part 1: Basic neurobiology.

J J Sandford1, S V Argyropoulos, D J Nutt.   

Abstract

The authors provide an overview of the current state of knowledge with regards to the neurobiological mechanisms involved in normal and pathological anxiety. A brief review of the classification and cognitive psychology of anxiety is followed by a more in-depth look at the neuroanatomical and neurochemical processes and their relevance to our understanding of the modes of action of anxiolytic drugs. The serotonergic, noradrenergic, and gamma-aminobutyric acidergic systems are reviewed. The numerous physiological and pharmacological methods of anxiety provocation and the increasing importance of functional neuroimaging are also examined. The review provides an overview of the biology and basic pharmacology of anxiolytic drugs, and compliments the more clinically oriented companion review.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11337025     DOI: 10.1016/s0163-7258(00)00082-6

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  11 in total

1.  Cellular correlates of anxiety in CA1 hippocampal pyramidal cells of 5-HT1A receptor knockout mice.

Authors:  Emily Freeman-Daniels; Sheryl G Beck; Lynn G Kirby
Journal:  Psychopharmacology (Berl)       Date:  2010-10-28       Impact factor: 4.530

2.  Estrogen decreases 5-HT1B autoreceptor mRNA in selective subregion of rat dorsal raphe nucleus: inverse association between gene expression and anxiety behavior in the open field.

Authors:  R Hiroi; J F Neumaier
Journal:  Neuroscience       Date:  2008-11-01       Impact factor: 3.590

Review 3.  Genetic animal models of anxiety.

Authors:  Deborah A Finn; Mark T Rutledge-Gorman; John C Crabbe
Journal:  Neurogenetics       Date:  2003-03-29       Impact factor: 2.660

4.  Mapping convulsants' binding to the GABA-A receptor chloride ionophore: a proposed model for channel binding sites.

Authors:  A V Kalueff
Journal:  Neurochem Int       Date:  2006-09-07       Impact factor: 3.921

5.  Estrogen receptor beta expression in the embryonic brain regulates development of calretinin-immunoreactive GABAergic interneurons.

Authors:  Xiaotang Fan; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-11       Impact factor: 11.205

6.  Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction.

Authors:  Elizabeth M Powell; Daniel B Campbell; Gregg D Stanwood; Caleb Davis; Jeffrey L Noebels; Pat Levitt
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

7.  EMD 281014, a specific and potent 5HT2 antagonist in humans: a dose-finding PET study.

Authors:  David Mamo; Ewen Sedman; Joachim Tillner; Edward M Sellers; Myroslava K Romach; Shitij Kapur
Journal:  Psychopharmacology (Berl)       Date:  2004-09       Impact factor: 4.530

8.  Anxiolytic activity of pyridoindole derivatives SMe1EC2 and SMe1M2: behavioral analysis using rat model.

Authors:  Natália Sedláčková; Veronika Ponechalová; Eduard Ujházy; Michal Dubovický; Mojmír Mach
Journal:  Interdiscip Toxicol       Date:  2011-12

9.  Evaluation of anxiolytic activity of compound Valeriana jatamansi Jones in mice.

Authors:  Jie-Shu You; Min Peng; Jin-Li Shi; Hu-Zhan Zheng; Yong Liu; Bao-Sheng Zhao; Jian-You Guo
Journal:  BMC Complement Altern Med       Date:  2012-11-21       Impact factor: 3.659

Review 10.  Neurobiology of memory and anxiety: from genes to behavior.

Authors:  Allan V Kalueff
Journal:  Neural Plast       Date:  2007-01-10       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.